Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: an integrative review
Keywords:
COVID-19, SARS-CoV-2, Down syndrome, Systematic review [publication type], Trisomy 21, Down syndrome comorbidities, Coronavirus disease 2019, Cytokine storm in coronavirus disease 2019, Outcomes of coronavirus disease 2019 in individuals with Down syndrome, Integrative reviewAbstract
BACKGROUND: Down syndrome (DS) is a non-rare genetic condition that affects approximately 1 in every 800 live births worldwide. Further, it is associated with comorbidities, anatomical alterations of the respiratory tract, and immunological dysfunctions that make individuals more susceptible to respiratory infections.
OBJECTIVE: To systematize the current scientific knowledge about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among individuals with DS.
DESIGN AND SETTING: This integrative review was conducted at the Universidade Federal de São Carlos, São Paulo, Brazil.
METHODS: This review was conducted in the following databases: the Virtual Health Library (Biblioteca Virtual em Saúde, BVS), PubMed, and Web of Science, using MeSH descriptors. The search included English or Portuguese studies published between January 1, 2020, and October 14, 2022.
RESULTS: A total of 55 articles from 24 countries were selected, comprising 21 case-control or cohort studies, 23 case reports or series, and 11 narrative reviews or opinion studies. The articles were grouped into five categories: previous comorbidities, coronavirus disease 2019 (COVID-19) clinical features and evolution, cytokine storm and interleukins, living in institutions as a risk factor, and behavioral actions as a protective factor against SARS-CoV-2 infection.
CONCLUSION: Individuals with DS are more susceptible to COVID-19 infection due to variables such as previous comorbidities, immunological factors, and their habitable environments. These aspects confer a higher risk of infection and an unfavorable clinical course. The precise pathways involved in the pathophysiology of COVID-19 in individuals with DS are not clear, thus requiring further studies.
SYSTEMATIC REVIEW REGISTRATION: The Open Science Framework registered the research protocol (https://osf.io/jyb97/).
Downloads
References
Bull MJ. Down syndrome. N Engl J Med. 2020;382(24):2344-52. PMID: 32521135; https://doi.org/10.1056/nejmra1706537.
Akhtar F, Bokhari SRA. Down syndrome. In: StatPearls. Treasure Island: StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih. gov/books/NBK526016/. PMID: 30252272. Accessed in 2023 (Feb 8).
Valentini D, Di Camillo C, Mirante N, et al. Medical conditions of children and young people with Down syndrome. J Intellect Disabil Res. 2021;65(2):199-209. PMID: 33426738; https://doi.org/10.1111/ jir.12804.
Dieudonné Y, Uring-Lambert B, Jeljeli MM, et al. Immune defect in adults with Down Syndrome: insights into a complex issue. Front Immunol. 2020;11:840. PMID: 32457756; https://doi.org/10.3389/ fimmu.2020.00840.
Patiroglu T, Cansever M, Bektas F. Underlying factors of recurrent infections in Down syndrome. North Clin Istanb. 2018;5(2):163-8. PMID: 30374487; https://doi.org/10.14744/nci.2017.69379.
Huggard D, Doherty DG, Molloy EJ. Immune dysregulation in children with Down syndrome. Front Pediatr. 2020;8:73. PMID: 32175298; https:// doi.org/10.3389/fped.2020.00073.
Vita S, Di Bari V, Corpolongo A, et al. Down syndrome patients with COVID-19 pneumonia: a high-risk category for unfavourable outcome. Int J Infect Dis. 2021;103:607-10. PMID: 33271290; http:// doi.org/10.1016/j.ijid.2020.11.188.
Callea M, Cammarata-Scalisi F, Galeotti A, Villani A, Valentini D. COVID-19 and Down syndrome. Acta Paediatr. 2020;109(9):1901-2. PMID: 32533572; http://doi.org/10.1111/apa.15409.
Whittemore R, Knafl K. The integrative review: Updated methodology. J Adv Nurs. 2005;52(5):546-53. PMID: 16268861; http://doi.org/10.1111/ j.1365-2648.2005.03621.x.
Hopia H, Latvala E, Liimatainen L. Reviewing the methodology of an integrative review. Scand J Caring Sci. 2016;30(4):662-9. PMID: 27074869; http://doi.org/10.1111/scs.12327.
da Silva RN, Brandão MAG, Ferreira MA. Integrative review as a method to generate or to test nursing theory. Nurs Sci Q. 2020;33(3):258-63. PMID: 32605480; https://doi.org/10.1177/0894318420920602.
Galvão TF, Pansani TSA, Harrad D. Principais itens para relatar revisões sistemáticas e meta-análises: a recomendação PRISMA. Epidemiol Serv Saúde. 2015;24(2):335-42. https://doi.org/10.5123/S167949742015000200017.
da Silva MVG, Melo DG. The behavior of SARS-CoV-2 infection among people with Down syndrome: an integrative review; 2022. Available from: https://osf.io/jyb97/. Accessed in 2023 (Feb 9).
Casarin ST, Porto AR, Gabatz RIB, et al. Types of literature review: considerations of the editors of the Journal of Nursing and Health. J Nurs Health. 2020;10(5):e20104031. https://doi.org/10.15210/jonah.v10i5.19924.
Cañón M, Buitrago-Gómez Q. The Research Question in Clinical Practice: A Guideline for Its Formulation. Rev Colomb Psiquiatr (Engl Ed). 2018;47(3):193-200. PMID: 30017043; https://doi.org/10.1016/j. rcp.2016.06.004.
da Silva MVG, Melo DG. The behavior of SARS-CoV-2 infection among people with Down syndrome: an integrative review [Internet]. Figshare; 2022. https://doi.org/10.6084/m9.figshare.21277452.v4.
Melnyk BM, Fineout-Overholt E. Making the case for evidence-based practice. In: Melnyk BM, Fineout-Overholt E, editors. Evidence-based practice in nursing and healthcare: a guide to best practice. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 3-24.
Kiger ME, Varpio L. Thematic analysis of qualitative data: AMEE Guide No. 131. Med Teach. 2020;42(8):846-54. PMID: 32356468; https://doi. org/10.1080/0142159x.2020.1755030.
Malle L, Gao C, Hur C, et al. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease. Genet Med. 2021;23(3):576-
PMID: 33060835; https://doi.org/10.1038/s41436-020-01004-w.
Emami A, Javanmardi F, Akbari A, Asadi-Pooya AA. COVID-19 in patients with Down syndrome. Neurol Sci. 2021;42(5):1649–52. PMID: 33523318; https://doi.org/10.1007/s10072-021-05091-8.
Clift AK, Coupland CAC, Keogh RH, Hemingway H, Hippisley-Cox J. COVID-19 mortality risk in down syndrome: results from a cohort study of 8 million adults. Ann Intern Med. 2021;174(4):572-6. PMID: 33085509; https://doi.org/10.7326/m20-4986.
Newman AM, Jhaveri R, Patel AB, et al. Trisomy 21 and coronavirus disease 2019 in pediatric patients. J Pediatr. 2021;228:294-6. PMID: 32861693; https://doi.org/10.1016/j.jpeds.2020.08.067.
Stefanuto PPG, Fernandes CJS, da Cruz CG, Leite RD, Tavares LVS. COVID-19 em criança com síndrome de down e tuberculose pulmonar extensa: relato de caso. Rev Bras Saúde Matern Infant. 2021;21(suppl 2):s559-s563. https://doi.org/10.1590/1806-9304202100S200013.
Simpson M, Collins C, Nash DB, Panesar LE, Oster ME. Coronavirus disease 2019 infection in children with pre-existing heart disease. J Pediatr. 2020;227:302-7. PMID: 32730815; https://doi.org/10.1016/j. jpeds.2020.07.069.
Perera B, Laugharne R, Henley W, et al. COVID-19 deaths in people with intellectual disability in the UK and Ireland: descriptive study. BJPsych open. 2020;6(6):e123. PMID: 33059790; https://doi.org/10.1192/ bjo.2020.102.
Oyanagi T, Tomita K, Furuichi M, Shinjoh M, Yamagishi H. Successful resuscitation from SARS-CoV-2 infection in a child after Rastelli operation. Pediatr Int. 2021;63(6):730-2. PMID: 34089270; https://doi.org/10.1111/ ped.14479.
Malle L, Bastard P, Martin-Nalda A, et al. Atypical inflammatory syndrome triggered by SARS-CoV-2 in infants with Down syndrome. J Clin Immunol. 2021;41(7):1457-62. PMID: 34089457; https://doi.org/10.1007/ s10875-021-01078-4.
Hüls A, Costa ACS, Dierssen M, et al. Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey. eClinicalMedicine.
;33:100769. PMID: 33644721; https://doi.org/10.1016/j.
eclinm.2021.100769.
Alsahabi I, Alobaidi A, Alahmari AS, Almohsen N, Alhamoud AH. Clinical presentation and successful management of an infant with
Down syndrome and COVID-19 in Riyadh, Saudi Arabia. Cureus. 2021;13(2):e13188. PMID: 33575158; https://doi.org/10.7759/ cureus.13188.
El Kaouini A, El Rhalete A, Aabdi M, et al. COVID 19 pneumonia in Down syndrome patients: About 2 cases. Ann Med Surg. 2021;65:102324. PMID: 33907623; https://doi.org/10.1016/j.amsu.2021.102324.
Illouz T, Biragyn A, Frenkel-Morgenstern M, et al. Specific susceptibility to COVID-19 in adults with Down syndrome. Neuromolecular Med. 2021;23(4):561-71. PMID: 33660221; https://doi.org/10.1007/s12017021-08651-5.
Amin MA, Khan II, Nahin S, et al. COVID-19 hospitalization with later long COVID in a person with Down syndrome. Clin Case Rep. 2022;10(10):e6425. PMID: 36245462; https://doi.org/10.1002/ccr3.6425.
Baksh RA, Strydom A, Pape SE, Chan LF, Gulliford MC. Susceptibility to COVID-19 diagnosis in people with Down syndrome compared to the general population: matched-cohort study using primary care electronic records in the UK. J Gen Intern Med. 2022;37(8):2009-15. PMID: 35386043; https://doi.org/10.1007/s11606-022-07420-9.
Pinku H, Hüls A, Feany PT, et al. Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey. J Glob Health. 2022;12:05035. PMID: 35932238; https://doi.org/10.7189/jogh.12.05035.
Silva DL, Lima CM, Magalhães VCR, et al. Down syndrome and COVID-19, a combination with a poor prognosis. Int J Tuberc Lung Dis. 2022;26(1):77-9. PMID: 34969435; https://doi.org/10.5588/ijtld.21.0605.
Kantar A, Mazza A, Bonanomi E, et al. COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course. BMC Pediatr. 2020;20(1):561. PMID: 33339516; https:// doi.org/10.1186/s12887-020-02471-5.
Real de Asua D, Mayer MA, Ortega MC, et al. Comparison of COVID-19 and non-COVID-19 pneumonia in Down syndrome. J Clin Med. 2021;10(16):3748. PMID: 34442043; https://doi.org/10.3390/ jcm10163748.
Villani ER, Carfì A, Di Paola A, et al. Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.
Am J Med Genet. 2020;182(12):2964-70. PMID: 32918520; https://doi. org/10.1002/ajmg.a.61867.
Robayo-Amortegui H, Valenzuela-Faccini N, Quecano-Rosas C, ZabalaMuñoz D, Perez-Garzon M. Cerebral venous thrombosis in a patient with
Down syndrome and coronavirus disease 2019: a case report. J Med Case Rep. 2021;15(1):364. PMID: 34253238; https://doi.org/10.1186/ s13256-021-02908-0.
Khoshnood M, Mahabir R, Shillingford NM, Santoro JD. Post-infectious inflammatory syndrome associated with SARS-CoV-2 in a paediatric patient with Down syndrome. BMJ Case Rep. 2021;14(4):e240490. PMID: 33858888; https://doi.org/10.1136/bcr-2020-240490.
Kim-Hellmuth S, Hermann M, Eilenberger J, et al. SARS-CoV-2 triggering severe acute respiratory distress syndrome and secondary hemophagocytic lymphohistiocytosis in a 3-year-old child with Down syndrome. J Pediatr Infect Dis Soc. 2021;10(4):543-6. PMID: 33188394; https://doi.org/10.1093/jpids/piaa148.
Krishnan US, Krishnan SS, Jain S, et al. SARS-CoV-2 infection in patients with Down syndrome, congenital heart disease, and pulmonary hypertension: is down syndrome a risk factor? J Pediatr. 2020;225:246-8. PMID: 32610168; https://doi.org/10.1016/j.jpeds.2020.06.076.
Kobayashi H, Akiniwa M, Yamaguchi Y, Hirai Y, Aoki A. COVID-19 in an adult with Down syndrome: impact on autoimmune response.
Case Rep Infect Dis. 2022;2022:6128496. PMID: 35433064; https://doi. org/10.1155/2022/6128496.
Kuczborska K, Buda P, Książyk JB. Different course of SARS-CoV-2 infection in two adolescents with other immunosuppressive factors. Cureus. 2022;14(2):e22710. PMID: 35386177; https://doi.org/10.7759/ cureus.22710.
Magalhães BK, Queiroz F, Salomão MLM, de Godoy MF. The impact of chronic cardiovascular disease on COVID-19 clinical course. J Clin Transl Res. 2022;8(4):308-22. PMID: 35991082.
Emes D, Hüls A, Baumer N, et al. Covid-19 in children with Down syndrome: Data from the Trisomy 21 Research Society Survey. J Clin Med. 2021;10(21):5125. PMID: 34768645; https://doi.org/10.3390/ jcm10215125.
Guffroy A, Dieudonné Y, Uring-Lambert B, et al. Infection risk among adults with down syndrome: A two group series of 101 patients in a tertiary center. Orphanet J Rare Dis. 2019;14(1):15. PMID: 30634988; https://doi.org/10.1186/s13023-018-0989-x.
Bayen E, Possin KL, Chen Y, Cleret de Langavant L, Yaffe K. Prevalence of aging, dementia, and multimorbidity in older adults with Down syndrome. JAMA Neurol. 2018;75(11):1399-406. PMID: 30032260; https:// doi.org/10.1001/jamaneurol.2018.2210.
Ma Y, Deutsch G, Van Tassel D, et al. SARS-CoV-2 Related ischemic colitis in an adolescent with trisomy 21: diagnostic pitfalls and considerations.
Pediatr Dev Pathol. 2021;24(5):445-9. PMID: 34048305; https://doi. org/10.1177/10935266211015666.
Majithia M, Ribeiro SP. COVID-19 and Down syndrome: the spark in the fuel. Nat Rev Immunol. 2022;22(7):404-5. PMID: 35672483; https://doi.
org/10.1038/s41577-022-00745-w.
Espinosa JM. Down Syndrome and COVID-19: A Perfect Storm?
Cell Reports Med. 2020;1(2):100019. PMID: 32501455; https://doi. org/10.1016/j.xcrm.2020.100019.
Parisini A, Boni S, Vacca EB, et al. Down syndrome and COVID-19: not always a poor prognosis. Int J Tuberc Lung Dis. 2022;26(7):691-3. PMID: 35768929; https://doi.org/10.5588/ijtld.22.0192.
De Toma I, Dierssen M. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19. Sci Rep. 2021;11(1):1930. PMID: 33479353; https://doi.org/10.1038/s41598-021-81451-w.
Evangelho VGO, Bello ML, Castro HC, Amorim MR. Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2. Neurol Sci. 2022;43(2):789-90. PMID: 34757552; https:// doi.org/10.1007/s10072-021-05715-z.
Williamson EJ, McDonald HI, Bhaskaran K, et al. Risks of covid-19 hospital admission and death for people with learning disability: Population based cohort study using the OpenSAFELY platform. BMJ. 2021;374:n1592. PMID: 34261639; https://doi.org/10.1136/bmj.n1592.
Semenzato L, Botton J, Drouin J, et al. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Heal Eur. 2021;8:100158. PMID: 34308411; https://doi.org/10.1016/j.lanepe.2021.100158.
Bergman J, Ballin M, Nordström A, Nordström P. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur J Epidemiol. 2021;36(3):287-98. PMID: 33704634; https://doi.org/10.1007/s10654-021-00732-w.
Boschiero MN, Lutti Filho JR, Ortega MM, Marson FAL. High case fatality rate in individuals with Down syndrome and COVID-19 in Brazil: a twoyear report. J Clin Pathol. 2022;75(10):717-20. PMID: 35764375; https:// doi.org/10.1136/jcp-2021-207802.
Ku JH, Levin MJ, Luo Y, et al. Risk of severe coronavirus disease 2019 disease in individuals with Down syndrome: a matched cohort study from a large, integrated health care system. J Infect Dis. 2022;226(5):757-
PMID: 35749312; https://doi.org/10.1093/infdis/jiac236.
Shi T, Pan J, Moore E, et al. Risk of COVID-19 hospitalizations among school-aged children in Scotland: A national incident cohort study. J Glob Health. 2022;12:05044. PMID: 36134546; https://doi.org/10.7189/ jogh.12.05044.
Lunsky Y, Durbin A, Balogh R, et al. COVID-19 positivity rates, hospitalizations and mortality of adults with and without intellectual and developmental disabilities in Ontario, Canada. Disabil Health J. 2022;15(1):101174. PMID: 34340949; https://doi.org/10.1016/j.dhjo.2021.101174.
Koyama A, Koumans EH, Sircar K, et al. Severe outcomes, readmission, and length of stay among COVID-19 patients with intellectual and developmental disabilities. Int J Infect Dis. 2022;116:328-30. PMID: 35077878; https://doi.org/10.1016/j.ijid.2022.01.038.
Hippisley-Cox J, Coupland CA, Mehta N, et al. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study. BMJ. 2021;374:n2244. PMID: 34535466; https://doi.org/10.1136/bmj.n2244.
Santos MM, Lucena EES, Lima KC, et al. Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in Brazil. Epidemiol Infect. 2020;148:e198. PMID: 32892789; https://doi.org/10.1017/s0950268820002034.
De Cauwer H, Spaepen A. Are patients with Down syndrome vulnerable to life-threatening COVID-19? Acta Neurol Belg. 2021;121(3):685-7. PMID: 32444942; https://doi.org/10.1007/s13760-020-01373-8.
Babamahmoodi A, Moniri A, Sadr M, et al. Trisomy 21 as a risk factor for severe illness in COVID-19: Report of two Cases. Tanaffos. 2020;19(4):413-
PMID: 33959180.
Altable M, de la Serna JM. Down’s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach. Neurol Sci. 2021;42(2):407-13. PMID: 33231770; https://doi.org/10.1007/ s10072-020-04880-x.
Illouz T, Biragyn A, Iulita MF, et al. Immune dysregulation and the increased risk of complications and mortality following respiratory tract infections in adults with Down syndrome. Front Immunol. 2021;12:621440. PMID: 34248930; https://doi.org/10.3389/fimmu.2021.621440.
Atkinson TP. Defective immune response to SARS-CoV-2 immunization in Down syndrome correlates with increased susceptibility to severe illness with infection. J Infect Dis. 2022;226(5):755-6. PMID: 35749348; https://doi.org/10.1093/infdis/jiac237.
Dard R, Janel N, Vialard F. COVID-19 and Down’s syndrome: are we heading for a disaster? Eur J Hum Genet. 2020;28(11):1477-8. PMID: 32686759; https://doi.org/10.1038/s41431-020-0696-7.
Wadman M. People with Down syndrome face high risk from coronavirus. Science. 2020;370(6523):1384-5. PMID: 33335039; https:// doi.org/10.1126/science.370.6523.1384.
Landes SD, Turk MA, Damiani MR, Proctor P, Baier S. Risk factors associated with COVID-19 outcomes among people with intellectual and developmental disabilities receiving residential services. JAMA Netw Open. 2021;4(6):e2112862. PMID: 34100935; https://doi.org/10.1001/ jamanetworkopen.2021.12862.
Stancliffe RJ, Lakin KC, Larson SA, et al. Demographic characteristics, health conditions, and residential service use in adults with Down syndrome in 25 U.S. states. Intellect Dev Disabil. 2012;50(2):92-108. PMID: 22642964; https://doi.org/10.1352/1934-9556-50.2.92.
Russo GC, Bernardes N, Baraldi NR, et al. Ações contra a Covid-19 na população com síndrome de Down. Arq Bras Cardiol. 2020;115(5):939-
PMID: 33295460; https://doi.org/10.36660/abc.20200685.
Del Carmen Ortega M, Borrel JM, de Jesús Bermejo T, et al. Lessons from individuals with Down syndrome during COVID-19. Lancet Neurol. 2020;19(12):974-5. PMID: 33212059; https://doi.org/10.1016/s14744422(20)30401-4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 São Paulo Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
